Ten of them (FN1, TLN1, ITGB3, HSPA8, TUBA4A, CD9, CD63, HSPG2, ITGB1, and GNAI2) that were measured in at least five samples were denoted as components of an EV proteomic signature associated with CRC. This evidence concerns the gene CD9 and colorectal carcinoma.